In addition, some members of the TRIM family regulate multiple signalling pathways (p53, NF‐κB, AKT, MAPK, Wnt/β‐catenin) and mediate the ubiquitination and proteasomal degradation of proteins, thereby promoting cancer proliferation, metastasis and resistance to cancer therapy. Here, NFKB1 is linked to cancer.